Risk factors for recurrent ischemic stroke in Turkey

Trakya Universitesi Tip Fakultesi Dergisi

Volumn 25, Issue 2, 2008, Pages 117-123

  Yalçin, Esra ^a   Yalçin, Murat ^b   Çelik, Yahya ^c,d   Ekuklu, Galip ^c  

^a Samsun State Hospital   (Turkey)

^b ONDOKUZ MAYIS UNIVERSITY   (Turkey)

^c TRAKYA UNIVERSITY   (Turkey)

^d TRAKYA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Ischemic; Recurrence; Risk factors; Stroke

Indexed keywords

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLOOD PRESSURE REGULATION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HEART ATRIUM FIBRILLATION; HEART DISEASE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; RANKIN SCALE; RECURRENT DISEASE; RISK FACTOR; STROKE PATIENT; TRANSIENT ISCHEMIC ATTACK; TURKEY (REPUBLIC);

EID: 70349102104     PISSN: 13013149     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. World Health Organization. The fact Sheet no: 310. The Top Ten Causes of Death. Avaible from: http:// www.who.int/mediacentre/factsheets/fs310.pdf
2. Samsa GP, Bian J, Lipscomb J, Matchar DB. Epidemiology of recurrent cerebral infarction: a medicare claims-based comparison of first and recurrent strokes on 2-year survival and cost. Stroke 1999; 30:338-349 (Pubitemid 29071799)
3. Sobel E, Alter M, Davanipour Z, Friday G, McCoy R, Levitt LP, et al. Stroke in the Lehigh Valley: combined risk factors for recurrent ischemic stroke. Neurology 1989;39:669-672 (Pubitemid 19126964)
4. Hier DB, Foulkes MA, Swiontoniowski M, Sacco RL, Gorelick PB, Mohr JP, et al. Stroke recurrence within 2 years after ischemic infarction. Stroke 1991;22:155-161
5. Sacco RL, Wolf PA, Kannel WB, McNamara PM. Survival and recurrence following stroke. The Framingham study. Stroke 1982;13:290-295
6. Petty GW, Brown RD Jr, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Survival and recurrence after first cerebral infarction: a population-based study in Rochester, Minnesota, 1975 through 1989. Neurology 1998;50:208-216
7. Goldstein LB, Adams R, Becker K, Furberg CD, Gorelick PB, Hademenos G, et al. Primary prevention of ischemic stroke: A statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke 2001;32:280-299 (Pubitemid 32063861)
8. Jørgensen HS, Nakayama H, Reith J, Raaschou HO, Olsen TS. Stroke recurrence: predictors, severity, and prognosis. The Copenhagen Stroke Study. Neurology 1997;48:891-895
9. Burn J, Dennis M, Bamford J, Sandercock P, Wade D, Warlow C. Long-term risk of recurrent stroke after a first-ever stroke. The Oxfordshire Community Stroke Project. Stroke 1994;25:333-337
10. Stroke-1989. Recommendations on stroke prevention, diagnosis, and therapy. Report of the WHO Task Force on Stroke and other Cerebrovascular Disorders. Stroke 1989;20:1407-1431
11. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41.
12. Bonita R, Beaglehole R. Recovery of motor function after stroke. Stroke 1988;19:1497-1500.
13. Wolf PA, Clagett GP, Easton JD, Goldstein LB, Gorelick PB, Kelly-Hayes M, et al. Preventing ischemic stroke in patients with prior stroke and transient ischemic attack: a statement for healthcare professionals from the Stroke Council of the American Heart Association. Stroke 1999;30:1991-1994
14. Messerli FH, Hanley DF Jr, Gorelick PB. Blood pressure control in stroke patients: what should the consulting neurologist advise? Neurology 2002;59:23-25
15. Irie K, Yamaguchi T, Minematsu K, Omae T. The J-curve phenomenon in stroke recurrence. Stroke 1993;24:1844-1849
16. Sacco RL, Shi T, Zamanillo MC, Kargman DE. Predictors of mortality and recurrence after hospitalized cerebral infarction in an urban community: the Northern Manhattan Stroke Study. Neurology 1994;44:626-634 (Pubitemid 24129987)
17. Farrell B, Godwin J, Richards S, Warlow C. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry 1991;54:1044-1054
18. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358:1033-1041 (Pubitemid 32925123)
19. Chalmers J. Trials on blood pressure-lowering and secondary stroke prevention. Am J Cardiol 2003;91:3G-8G. (Pubitemid 36638515)
20. Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. EAFT (European Atrial Fibrillation Trial) Study Group. Lancet 1993;342:1255-1262
21. Hankey GJ. Warfarin-Aspirin Recurrent Stroke Study (WARSS) trial: is warfarin really a reasonable therapeutic alternative to aspirin for preventing recurrent noncardioembolic ischemic stroke? Stroke 2002;33:1723-1726
22. Sudlow M, Thomson R, Thwaites B, Rodgers H, Kenny RA. Prevalence of atrial fibrillation and eligibility for anticoagulants in the community. Lancet 1998;352:1167-1171 (Pubitemid 28458530)
23. Kolominsky-Rabas PL, Sarti C, Heuschmann PU, Graf C, Siemonsen S, Neundoerfer B, et al. A prospective community-based study of stroke in Germany-the Erlangen Stroke Project (ESPro): incidence and case fatality at 1, 3, and 12 months. Stroke 1998;29:2501-2506
24. Yamamoto H, Bogousslavsky J. Mechanisms of second and further strokes. J Neurol Neurosurg Psychiatry 1998;64:771-776